Zydus Wellness Limited shareholders approved the appointment of Mr. Apurva S. Diwanji as an Independent Director for a five-year term and re-elected Dr. Sharvil P. Patel as a Non-Executive Director during its 32nd Annual General Meeting (AGM) held on August 4, 2026. While the resolutions passed with requisite majorities, they faced significant opposition from institutional investors, highlighting a divergence in governance preferences between promoters and public institutional stakeholders. The meeting also approved a ₹1.20 per share dividend for FY26.

The appointment of Mr. Diwanji was formalized via a special resolution that received 87.48% support overall. However, a breakdown of the voting data reveals that while the promoter group voted unanimously in favor, Public – Institutions voted against the resolution by 53.1974%. Similarly, Dr. Patel’s re-election, an ordinary resolution, passed with 97.42% support but saw 10.88% opposition from institutional investors. The divergence suggests specific concerns among large block holders regarding board composition, despite near-unanimous approval (>99.99%) for financial statements and cost auditor remuneration.

AGM Voting Results

The AGM was conducted through Video Conferencing and Other Audio Visual Means (OAVM). Remote e-voting was open from July 31, 2026, to August 3, 2026. Central Depository Services (India) Limited provided the e-voting facility, and Mr. Hitesh D. Buch was appointed as Scrutinizer under Section 109 of the Companies Act, 2013.

Mr. Diwanji brings over 32 years of experience in mergers and acquisitions, private equity, and joint ventures from his tenure at Desai & Diwanji. He holds a Master of Arts in Law from Downing College, Cambridge University, and a Bachelor of Arts in Economics from St. Xavier’s College, Mumbai. He currently serves as an Independent Director at Torrent Power Limited, Bajaj Life Insurance Limited, Bajaj General Insurance Limited, and TUV India Private Limited. Until May 12, 2026, he was an Independent Director at Zydus Lifesciences Limited. His term runs from May 18, 2026, to May 17, 2031.

What the Numbers Show

The voting pattern highlights a clear split between promoter and institutional shareholder preferences regarding board composition. Promoters voted unanimously (100%) in favor of both Mr. Diwanji’s appointment and Dr. Patel’s re-election. In contrast, Public – Institutions opposed Mr. Diwanji’s appointment by 53.1974% and Dr. Patel’s re-election by 10.8771%. This contrasts sharply with the near-perfect consensus (>99.99%) on financial statements, dividend declarations, and cost auditor remuneration. The data indicates that while operational and financial strategies are broadly aligned, governance structures remain a point of contention for institutional stakeholders.

Zydus Wellness has released the audio recording of its investor call concerning the unaudited financial results for the quarter ended June 30, 2026. The recording is now available on the company’s official website, allowing stakeholders to review management’s commentary on the Q1FY27 performance. This disclosure ensures transparency and provides investors with direct access to the detailed discussion surrounding the quarterly figures.

The release of the recording was mandated under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Zydus Wellness Limited submitted the notice to both the BSE Limited and the National Stock Exchange of India Limited on August 4, 2026. The company secretary, Nandish P. Joshi, digitally signed the communication, confirming compliance with listing obligations.

Accessing the Recording

Investors can access the audio file directly through the link provided in the exchange filing. The recording covers the unaudited results for the quarter ended June 30, 2026.

Compliance and Disclosure

The notice was issued by the Listing Department of Zydus Wellness Limited, headquartered at Zydus Corporate Park in Ahmedabad. The filing confirms that the audio recording is hosted on the company’s investor relations page. This procedural step follows the standard timeline for post-result disclosures, ensuring that all market participants have equal access to the information presented during the conference call.

No specific financial metrics were detailed in this particular filing, as it serves solely as a pointer to the audio recording. Investors seeking quantitative data should refer to the separate financial results announcement or listen to the provided recording for a comprehensive breakdown of revenue, profit, and operational highlights for Q1FY27.